| Name | 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine |
|---|---|
| Synonyms |
β-Acetyl-γ-O-hexadecyl-L-α-phosphatidylcholine
PAF Platelet-activating factor [(2R)-2-acetyloxy-3-hexadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate 1-O-HEXADECYL-2-ACETYL-SN-GLYCERO-3-PHOSPHOCHOLINE 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine PAF Acether AcGEPC PAF(C16) MFCD00043214 (2R)-2-Acetoxy-3-(hexadecyloxy)propyl 2-(trimethylammonio)ethyl phosphate Ethanaminium, 2-[[[(2R)-2-(acetyloxy)-3-(hexadecyloxy)propoxy]hydroxyphosphinyl]oxy]-N,N,N-trimethyl-, inner salt |
| Description | C16-PAF is an endogenous platelet-activating factor (PAF) and ligand for PAF receptors. C16-PAF is produced by inflammatory cells and a potent chemoattractant for polymorphonuclear neutrophils. C16-PAF induces increased vascular permeability. |
|---|---|
| Target |
Human Endogenous Metabolite |
| Molecular Formula | C26H54NO7P |
|---|---|
| Molecular Weight | 523.683 |
| Exact Mass | 523.363770 |
| PSA | 103.93000 |
| LogP | 3.94 |
| Appearance | lyophilized powder |
| Storage condition | −20°C |
| Hazard Codes | Xn: Harmful; |
|---|---|
| Risk Phrases | 22-38-40-48/20/22 |
| Safety Phrases | 36/37-24/25-22 |
| RIDADR | UN 1888 6.1/PG 3 |
| WGK Germany | 3 |
| RTECS | EC6060000 |
| Precursor 9 | |
|---|---|
| DownStream 0 | |